¨ ¨ ¨
K. Parikka and K. Wahala
argon for 20 h at 1301C. The solution was allowed to cool down 107.2, 144.9, 161.3; MS (EI, 70 eV) m/z (%) 152 (100), 191 (25), 203
and evaporated. The product was crystallized from Et2O as a (10), 217 (12), 259 (7), 274 (5) M1.
white powder (isotopologues 2H2-2H7, 2H3-2H5 as the main
products, 0.11 g, 71%). 1H NMR (200 MHz, CDCl3) d 0.82–0.87 (m, Deuterogenation of 19
3H, CH3), 1.18–1.36 (m, ca. 26H, CH2), 1.56–1.66 (m, 2H, CH2),
1-(3,5-Dimethoxyphenyl)-4-decyne (19) (0.024g, 0.087 mmol) was
3.66–3.86 (m, 2H, H-1), 7.54–7.88 (m, 15H, ArH).
stirred in CH2Cl2 containing 0.003 g of Pd/C (10% w/w) and
connected to a balloon containing deuterium gas. The mixture
was stirred overnight at room temperature. Filtration of the
Deuterated 1-(3,5-dimethoxyphenyl)-1-nonadecene 16
reaction mixture through Celites gave 20 (isotopologues 2H3,
The phosphonium salt 15 (0.10 g, 0.17 mmol) was stirred with n-
18%; 2H4, 20%; 2H5, 20%; 2H6, 19% as the main products; 0.023 g,
BuLi (0.15 ml, 1.2 M solution in hexane) in THF (10 ml) for 10 min
95%). MS (EI, 70eV) m/z (%) 151 (10), 152 (90), 153 (100), 154 (60),
under argon at 01C. 3,5-Dimethoxybenzaldehyde (0.028 g,
155 (20), 281 (11), 282 (14), 283 (13), 284 (13), 285 (9), 286 (6).
0.17 mmol) was added and the solution refluxed overnight.
Water was added and the product extracted with Et2O
[1,1-2H2]-12-(3,5-Dimethoxyphenyl)dodecan-1-ol 22
(3 ꢀ 20 ml). Combined extracts were washed with brine and
dried over Na2SO4. The product was purified by flash
Methyl 12-(3,5-dimethoxyphenyl)dodecanoate 21 (0.075 g,
chromatography eluting with hexane/CH2Cl2 2/3 to give a
0.21 mmol) and LiAlD4 (0.040 g, 0.84 mmol) were refluxed in
2
2
2
2
colourless oil (isotopologues H2, 10%; H3, 21%; H4, 31%; H5,
13%; 2H6, 17%; 2H7, 6%; 0.045 g, 65%). MS (EI, 70 eV) m/z (%) 151
(20), 152 (100), 153 (50), 154 (20), 179 (25), 404 (15), 405 (35), 406
(50), 407 (35), 408 (25), 409 (15).
dry THF for 3 h. Water was added and the mixture was acidified
with 0.1 M HCl. The product was extracted with EtOAc
(3 ꢀ 10 ml). Combined extracts were washed with brine and
dried over Na2SO4. Evaporation gave 22 as a white powder
which was used in the next step without purification (0.070 g,
93%). 1H NMR (300 MHz, CDCl3) d 1.26–1.35 (m, 16H, CH2),
1.53–1.60 (m, 4H, CH2), 2.54 (t, 2H, J 5 7.6 Hz, CH2Ar), 3.78 (s, 6H,
OMe), 6.29 (t, 1H, J 5 2.1 Hz, H-40), 6.34 (d, 2H, J 5 2.1 Hz, H-20
and H-60); 13C NMR (300 MHz, CDCl3) d 25.7, 29.3, 29.4, 29.6, 31.3,
31.8, 32.6, 36.3, 55.2, 97.6, 106.5, 145.4, 160.7.
Deuterated 1-(3,5-dimethoxyphenyl)nonadecane 17
The nonadecene 16 (0.01 g, 0.025 mmol) was hydrogenated by
H2 gas in CH2Cl2 containing 0.001 g of Pd/C (10% w/w) under
atmospheric pressure and room temperature. Filtration of the
reaction mixture through Celites gave 17 (isotopologues 2H2,
2
2
2
2
2
11%; H3, 20%; H4, 29%; H5, 20%; H6, 12%; H7, 7%; 0.009 g,
89%). MS (EI, 70 eV) m/z (%) 151 (20), 152 (100), 153 (60), 154
(25), 406 (12), 407 (25), 408 (30), 409 (25), 410 (20), 411 (10).
[1,1-2H2]-12-(3,5-Dimethoxyphenyl)dodecyl toluenesulpho-
nate 23
[1,1-2H2]-12-(3,5-Dimethoxyphenyl)dodecan-1-ol 22 (0.06 g,
0.18 mmol), toluenesulphonyl chloride (0.041 g, 0.22 mmol) and
Et3N (0.04 ml) were stirred in CH2Cl2 (5 ml) at room temperature
overnight. Water was added and the product extracted with
CH2Cl2 (3 ꢀ 10 ml). Combined extracts were washed with brine
and dried over Na2SO4. Flash chromatography on silica gel
1-Decen-4-yne 18
1-Heptyne (0.50 g, 0.52 mmol, 0.68 ml), n-BuLi (4.2 ml, 1.25 M
solution in hexane) and THF (7 ml) were stirred at ꢁ721C under
argon for 1 h. 1-Bromopropene (0.63 g, 0.52 mmol, 0.44 ml) was
added and the solution stirred at room temperature overnight.
Water was added and the product extracted with hexane
(2 ꢀ 30 ml). The combined extracts were dried over MgSO4.
Distillation under reduced pressure gave 18 as a colourless oil
(0.3 g, 43%), b.p. 72–731C/22 mmHg (Lit. 73–741C/22 mmHg18).
1H NMR (200 MHz, CDCl3) d 0.85–0.93 (m, 3H, CH3), 1.31–1.55 (m,
6H, CH2), 2.10–2.25 (m, 2H, H-6), 2.90–2.97 (m, 2H, H-3), 5.05–5.15
(m, 1H, H-1), 5.25–5.35 (m, 1H, H-1), 5.75–5.95 (m, 1H, H-2).
1
eluting with CH2Cl2 gave 23 (0.053 g, 62%). H NMR (300 MHz,
CDCl3) d 1.21–1.29 (m, 16H, CH2), 1.53–1.64 (m, 4H, CH2), 2.44 (s,
3H, CH3), 2.54 (t, 2H, J 5 7.6 Hz, CH2Ar), 3.78 (s, 6H, OMe), 6.29 (t,
1H, J 5 2.1 Hz, H-40), 6.34 (d, 2H, J 5 2.1 Hz, H-20 and H-60), 7.34
(d, 2H, J 5 8.0 Hz, ArH), 7.79 (d, 2H, J 5 8.0 Hz, ArH); 13C NMR
(300 MHz, CDCl3) d 21.6, 25.3, 28.6, 28.9, 29.4, 29.5, 31.3,
36.3, 55.2, 97.6, 106.5, 127.9, 129.8, 145.4, 160.7; MS (EI, 70 eV)
m/z (%) 91 (45), 151 (45), 152 (100), 194 (10), 306 (10), 478 (20)
M1, 479 (5).
1-(3,5-dimethoxyphenyl)-4-decyne 19
1-Decen-4-yne 18 (0.05 g, 0.37 mmol), 9-BBN (1.5 ml, 0.5 M
solution in THF) and dry THF (11 ml) were stirred under argon
[12,12,12-2H3]-1-(3,5-Dimethoxyphenyl)dodecane 24
at room temperature for 2.5 h. NaOMe (0.046 g, 0.86 mmol), [1,1-2H2]-12-(3,5-Dimethoxyphenyl)dodecyl toluenesulphonate
PdCl2 (dppf) (0.016 g, 0.02 mmol) and 3,5-dimethoxyphenol 23 (0.050 g, 0.1 mmol) and NaBD4 (0.009 g, 0.21 mmol) were
trifluoromethanesulfphonate (0.19 g, 0.66 mmol) were added stirred under MW irradiation (100 W, 851C) for 8 min in DMSO
and the mixture refluxed for 2 h. Water was added and the (2 ml). Water was added and the product extracted with Et2O
product extracted with Et2O (3 ꢀ 20 ml). The combined extracts (3 ꢀ 10 m). The combined extracts were dried over Na2SO4. Flash
were washed with brine and dried over Na2SO4. The product chromatography on silica gel eluting with CH2Cl2 gave 24
was purified by flash chromatography eluting with CH2Cl2/ (0.019 g, 63%). 1H NMR (300 MHz, CDCl3) d 1.26–1.31 (m, 18H,
hexane 2/1 to give a colourless oil (0.024 g, 24%). 1H NMR CH2), 1.53–1.64 (m, 2H, CH2), 2.54 (t, 2H, J 5 7.8 Hz, CH2Ar), 3.78
(200 MHz, CDCl3) d 0.88–0.94 (m, 3H, CH3), 1.34–1.57 (m, 6H, (s, 6H, OMe), 6.30 (t, 1H, J 5 2.1 Hz, H-40), 6.35 (d, 2H, J 5 2.1 Hz,
CH2), 1.75–1.85 (m, 2H, CH2), 2.14–2.20 (m, 4H, CH2), 2.66 (t, 2H, H-20 and H-60); 13C NMR (300 MHz, CDCl3) d 13.9, 22.4, 29.4, 29.5,
J 5 7.6 Hz, CH2Ar), 3.78 (s, 6H, OCH3), 6.30 (t, 1H, J 5 2.2 Hz, H-4), 29.7, 31.3, 31.9, 36.3, 55.2, 97.6, 106.5, 145.5, 160.7; MS (EI, 70 eV)
6.36 (d, 2H, J 5 2.2 Hz, H-2 and H-6); 13C NMR (200 MHz, CDCl3) d m/z (%) 121 (10), 151 (55), 152 (100), 165 (40), 194 (10), 308 (5),
14.6, 18.9, 19.3, 22.8, 29.5, 31.1, 31.7, 35.7, 55.8, 80.2, 81.5, 98.4, 309 (30) M1, 310 (5).
J. Label Compd. Radiopharm 2008, 51 12–18
Copyright r 2008 John Wiley & Sons, Ltd.